1. Home
  2. PNNT vs BNTC Comparison

PNNT vs BNTC Comparison

Compare PNNT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

HOLD

Current Price

$4.90

Market Cap

397.7M

Sector

Finance

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.39

Market Cap

371.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNNT
BNTC
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.7M
371.0M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
PNNT
BNTC
Price
$4.90
$11.39
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$5.85
$27.67
AVG Volume (30 Days)
818.9K
159.4K
Earning Date
01-01-0001
05-22-2026
Dividend Yield
19.01%
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.84
$9.85
52 Week High
$7.53
$17.15

Technical Indicators

Market Signals
Indicator
PNNT
BNTC
Relative Strength Index (RSI) 31.83 51.96
Support Level $4.84 $11.30
Resistance Level $6.18 $12.75
Average True Range (ATR) 0.14 0.73
MACD 0.01 0.07
Stochastic Oscillator 11.84 90.34

Price Performance

Historical Comparison
PNNT
BNTC

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: